Compounds having dopaminegic activity are provided, having the formula: ##STR1## wherein R.sup.1 and R.sup.2 are each, independently, hydrogen, C.sub.1-10 alkyl, or (CH.sub.2).sub.m R.sup.4, wherein R.sup.4 is phenyl or naphthyl which may be substituted by one or two substituents selected from the group consisting of C.sub.1-6 alkyl, halogen, C.sub.1-6 alkoxide and trifluoromethyl and m is 1 to 5; and R.sup.3 is hydrogen or C.sub.1-6 alkyl; or pharmaceutically acceptable salts thereof.

Los compuestos que tienen actividad dopaminegic se proporcionan, teniendo el fórmula: ## del ## STR1 en donde R.sup.1 y R.sup.2 son cada uno, independientemente, hidrógeno, el alkyl C.sub.1-10, o (CH.sub.2).sub.m R.sup.4, en donde R.sup.4 es fenilo o la naftílico que se puede substituir por un o dos sustitutos seleccionados del grupo que consiste en el alkyl C.sub.1-6, halógeno, el alkoxide C.sub.1-6 y trifluoromethyl y m es 1 a 5; y R.sup.3 es hidrógeno o el alkyl C.sub.1-6; o farmacéutico sales aceptables de eso.

 
Web www.patentalert.com

< (none)

< Aromatic heterocyclic compounds and their use as anti-inflammatory agents

> Methods and compositions for inhibition of angiogenesis

> (none)

~ 00007